Achieve Life Sciences (ACHV) Other Non Operating Income (2010 - 2026)
Achieve Life Sciences (ACHV) posted Other Non Operating Income of -$13000.0 for Q1 2026, down 285.71% on a QoQ basis from $7000.0 in Q4 2025, and down 161.9% year-over-year from $21000.0 in Q1 2025.
Achieve Life Sciences (ACHV) Other Non Operating Income (2010 - 2026) Analysis & Trends
Achieve Life Sciences' Other Non Operating Income history runs 17 years deep, the most recent figure standing at -$13000.0 for Q1 2026.
- Quarterly Other Non Operating Income fell 161.9% year-over-year to -$13000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$70000.0 (up 71.66% YoY) and the FY2025 annual result came in at -$36000.0, up 87.28% from the prior year.
- Other Non Operating Income was -$13000.0 for Q1 2026 at Achieve Life Sciences, down from $7000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $59000.0 in Q4 2022 and bottomed at -$258000.0 in Q4 2024.
- A 5-year average of -$17705.9 and a median of -$5000.0 in 2025 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 251.28% in 2022, while the deepest fall reached 2900.0% in 2022.
- Achieve Life Sciences' Other Non Operating Income stood at $59000.0 in 2022, then sank by 71.19% to $17000.0 in 2023, then slumped by 1617.65% to -$258000.0 in 2024, then jumped by 102.71% to $7000.0 in 2025, then tumbled by 285.71% to -$13000.0 in 2026.
- Business Quant data shows ACHV's Other Non Operating Income at -$13000.0 in Q1 2026, $7000.0 in Q4 2025, and -$5000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Achieve Life Sciences | 2.54 Mn | 2.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Sep 30, 2025 | -5,000.00 |
| Jun 30, 2025 | -59,000.00 |
| Mar 31, 2025 | 21,000.00 |
| Dec 31, 2024 | -258,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -15,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Sep 30, 2023 | -17,000.00 |
| Jun 30, 2023 | -6,000.00 |
| Mar 31, 2023 | -3,000.00 |
| Dec 31, 2022 | 59,000.00 |
| Sep 30, 2022 | -30,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | 6,000.00 |
| Dec 31, 2021 | -39,000.00 |
| Sep 30, 2021 | -1,000.00 |
| Jun 30, 2021 | -12,000.00 |